COVID 19 Spike S1 Protein (Uk Variant B.1.1.7) Coronavirus (COVID-19) Recombinant Protein

C-terminal His-tagged, HEK293 expressed.
C-terminal his-tagged recombinant SARS-CoV-2 S1 protein (aa 16-683) of the UK variant B.1.1.7 (GenBank Accession No. MW422256)

The novel coronavirus (SARS-CoV-2), previously called 2019-nCoV, is a newly identified coronavirus causing the ongoing outbreak of atypical pneumonia in Wuhan China from late 2019.

The genome of SARS-CoV-2 has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV. The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleocapsid protein also clustered closely with those of the bat, civet and human SARS coronaviruses. However, the external subdomain of Spike's receptor binding domain (RBD) of SARS-CoV-2 shares only 40% amino acid identity with other SARS-related coronaviruses.

Recombinant SARS-CoV-2 S1 protein of the UK variant B.1.1.7 purified from 293 cells

Small volumes of COVID-19 recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS434293 is a recombinant protein targeting COVID-19. Also known as Spike S1 Protein (SARS-CoV-2 UK Variant B.1.1.7). Host: HEK293 Cells.